AL
VRTX icon

AJO LP’s Vertex Pharmaceuticals VRTX Stock Holding History

AJO LP’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,649
Closed -$862K – 243
2020
Q4 		$862K Sell
3,649
-104,678
-97% -$24M 0.09% 185
2020
Q3 		$29.5M Buy
108,327
+39,163
+57% +$10.8M 0.31% 91
2020
Q2 		$20.1M Buy
69,164
+15,502
+29% +$4.2M 0.18% 128
2020
Q1 		$12.8M Buy
+53,662
New +$12.3M 0.11% 180
2019
Q3 		– Sell
-7,172
Closed -$1.31M – 716
2019
Q2 		$1.31M Sell
7,172
-28,531
-80% -$4.99M 0.01% 455
2019
Q1 		$6.57M Buy
35,703
+374
+1% +$69.1K 0.03% 278
2018
Q4 		$5.85M Buy
+35,329
New +$6.12M 0.03% 282
2018
Q3 		– Sell
-13,623
Closed -$2.31M – 729
2018
Q2 		$2.31M Sell
13,623
-26,528
-66% -$4.11M 0.01% 446
2018
Q1 		$6.54M Sell
40,151
-520,223
-93% -$85M 0.03% 284
2017
Q4 		$84M Buy
560,374
+45,655
+9% +$6.76M 0.36% 90
2017
Q3 		$78.3M Sell
514,719
-43,645
-8% -$6.57M 0.34% 89
2017
Q2 		$72M Buy
+558,364
New +$67.2M 0.31% 95

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AJO LP's VRTX Position: Q1 2021 in Review

AJO LP sold out of Vertex Pharmaceuticals (VRTX) in Q1 2021, closing a stake of 3,649 shares — an estimated $862K sold.

AJO LP first reported a position in VRTX in Q2 2017 and held it in 12 quarters. The position peaked at $84M in Q4 2017. 999 funds tracked by Wall St. Rank hold VRTX as of Q1 2021.

  • AJO LP reported no remaining Vertex Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • AJO LP sold 3,649 Vertex Pharmaceuticals shares in Q1 2021, an estimated $862K.
  • AJO LP first reported a position in Vertex Pharmaceuticals in Q2 2017 and held it in 12 quarters.
  • AJO LP's Vertex Pharmaceuticals position peaked at $84M in Q4 2017.
  • 999 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2021.

Based on AJO LP's 13F filing for Q1 2021, filed 7 May 2021.